{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:31Z","timestamp":1787026291029,"version":"build-2736575974"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Malignant gliomas occur more often in adults and may affect any part of the central nervous system (CNS). Although their results could be better, surgical excision, postoperative radiation and chemotherapy, and electric field therapy are today\u2019s mainstays of glioma care. However, bacteria can also exert anti-tumor effects\n                    <jats:italic>via<\/jats:italic>\n                    mechanisms such as immune regulation and bacterial toxins to promote apoptosis, inhibit angiogenesis, and rely on their natural characteristics to target the tumor microenvironment of hypoxia, low pH, high permeability, and immunosuppression. Tumor-targeted bacteria expressing anticancer medications will go to the cancer site, colonize the tumor, and then produce the therapeutic chemicals that kill the cancer cells. Targeting bacteria in cancer treatment has promising prospects. Rapid advances have been made in the study of bacterial treatment of tumors, including using bacterial outer membrane vesicles to load chemotherapy drugs or combine with nanomaterials to fight tumors, as well as the emergence of bacteria combined with chemotherapy, radiotherapy, and photothermal\/photodynamic therapy. In this study, we look back at the previous years of research on bacteria-mediated glioma treatment and move forward to where we think it is headed.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2023.1164654","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T01:27:05Z","timestamp":1682990825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Bacteria associated with glioma: a next wave in cancer treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Yiming","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2023.01.002","article-title":"Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors","volume":"89","author":"Ahmad","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1046472","article-title":"Immunological consequences of microbiome-based therapeutics","volume":"13","author":"Alam","year":"2022","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122742","article-title":"Lipid and polymeric nanoparticles: successful strategies for nose-to-Brain drug delivery in the treatment of depression and anxiety disorders","volume":"14","author":"Alberto","year":"2022","journal-title":"Pharmaceutics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005657","article-title":"Tumor-associated neutrophils and macrophages exacerbate antidrug IgG-mediated anaphylactic reaction against an immune checkpoint inhibitor","volume":"10","author":"Arai","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev-animal-013120-043304","article-title":"Salmonella in swine: prevalence, multidrug resistance, and vaccination strategies","volume":"10","author":"Bearson","year":"2022","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"B7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"},{"key":"B8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13046-022-02552-6","article-title":"Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed glioblastoma patients: safety and efficacy assessment","volume":"41","author":"Bota","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"CCR-22-1896","DOI":"10.1158\/1078-0432.CCR-22-1896","article-title":"Zinc finger MYND-type containing 8 (ZMYND8) is epigenetically regulated in mutant isocitrate dehydrogenase 1 (IDH1) glioma to promote radioresistance","volume":"22","author":"Carney","year":"2023","journal-title":"Clin. Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1038\/s41467-022-31932-x","article-title":"Spatiotemporal control of engineered bacteria to express interferon-gamma by focused ultrasound for tumor immunotherapy","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"120179","DOI":"10.1016\/j.lfs.2021.120179","article-title":"Lactate-utilizing bacteria ameliorates DSS-induced colitis in mice","volume":"288","author":"Chen","year":"2022","journal-title":"Life Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"114696","DOI":"10.1016\/j.addr.2023.114696","article-title":"Bacteria-based bioactive materials for cancer imaging and therapy","volume":"193","author":"Chen","year":"2023","journal-title":"Adv. Drug Delivery Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jare.2022.03.007","article-title":"Roles of oral microbiota and oral-gut microbial transmission in hypertension","volume":"43","author":"Chen","year":"2023","journal-title":"J. Adv. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/toxins12050291","article-title":"Cnf1 variants endowed with the ability to cross the blood-brain barrier: a new potential therapeutic strategy for glioblastoma","volume":"12","author":"Colarusso","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c10219","article-title":"Immune exosomes loading self-assembled nanomicelles traverse the blood-brain barrier for chemo-immunotherapy against glioblastoma","volume":"17","author":"Cui","year":"2023","journal-title":"ACS Nano"},{"key":"B16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.201948354","article-title":"Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice","volume":"50","author":"D'Alessandro","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.1073\/pnas.1801910115","article-title":"Recombinant listeria promotes tumor rejection by CD8(+) T cell-dependent remodeling of the tumor microenvironment","volume":"115","author":"Deng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205007","article-title":"Membrane targeted azobenzene drives optical modulation of bacterial membrane potential","volume":"10","author":"de Souza-Guerreiro","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1021\/acs.langmuir.8b00114","article-title":"Living bacteria-nanoparticle hybrids mediated through surface-displayed peptides","volume":"34","author":"Dong","year":"2018","journal-title":"Langmuir"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010272","article-title":"Current state of immunotherapy and mechanisms of immune evasion in Ewing sarcoma and osteosarcoma","volume":"15","author":"Evdokimova","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12247","article-title":"Generalized modules for membrane antigens (GMMA), an outer membrane vesicle-based vaccine platform, for efficient viral antigen delivery","volume":"11","author":"Hu","year":"2022","journal-title":"J. Extracell Vesicles"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/nano12020288","article-title":"Bacteria-assisted transport of nanomaterials to improve drug delivery in cancer therapy","volume":"12","author":"Jimenez-Jimenez","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"114400","DOI":"10.1016\/j.addr.2022.114400","article-title":"Microbiome as an immune regulator in health, disease, and therapeutics","volume":"188","author":"Juarez","year":"2022","journal-title":"Adv. Drug Delivery Rev."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.02.009","article-title":"Ultrasound-mediated nano drug delivery for treating cancer: fundamental physics to future directions","volume":"355","author":"Kashkooli","year":"2023","journal-title":"J. Control Release"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jconrel.2023.02.001","article-title":"ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models","volume":"355","author":"Kim","year":"2023","journal-title":"J. Control Release"},{"key":"B27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bioactmat.2023.01.006","article-title":"Potential alzheimer's disease therapeutic nano-platform: discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles","volume":"24","author":"Kim","year":"2023","journal-title":"Bioact Mater"},{"key":"B29","doi-asserted-by":"publisher","first-page":"154642","DOI":"10.1016\/j.phymed.2023.154642","article-title":"Phytotherapy of mood disorders in the light of microbiota-gut-brain axis","volume":"111","author":"Korczak","year":"2023","journal-title":"Phytomedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/cells12030508","article-title":"Novel zebrafish patient-derived tumor xenograft methodology for evaluating efficacy of immune-stimulating BCG therapy in urinary bladder cancer","volume":"12","author":"Kowald","year":"2023","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1079136","article-title":"The role of microbial ecology in improving the performance of anaerobic digestion of sewage sludge","volume":"13","author":"Krohn","year":"2022","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"114708","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles","volume":"194","author":"Kumar","year":"2023","journal-title":"Adv. Drug Delivery Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s40168-022-01435-4","article-title":"Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses","volume":"10","author":"Kunath","year":"2022","journal-title":"Microbiome"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004779","article-title":"Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma","volume":"10","author":"Lee","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2020.05.032","article-title":"Hypoxia-responsive nanoparticles for tumor-targeted drug delivery","volume":"490","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"160461","DOI":"10.1016\/j.scitotenv.2022.160461","article-title":"Bacterial resistance to antibacterial agents: mechanisms, control strategies, and implications for global health","volume":"860","author":"Li","year":"2023","journal-title":"Sci. Total Environ."},{"key":"B37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"key":"B38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.semcancer.2021.05.005","article-title":"Metabolic regulation on the immune environment of glioma through gut microbiota","volume":"86","author":"Lyu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-021-00301-9","article-title":"The role of polyphenols in overcoming cancer drug resistance: a comprehensive review","volume":"27","author":"Maleki Dana","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.biopha.2018.02.140","article-title":"New therapeutics from nature: the odd case of the bacterial cytotoxic necrotizing factor 1","volume":"101","author":"Maroccia","year":"2018","journal-title":"BioMed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2022.11.024","article-title":"Glioblastoma immuno-endothelial multicellular microtissue as a 3D in vitro evaluation tool of anti-cancer nano-therapeutics","volume":"353","author":"Martins","year":"2023","journal-title":"J. Control Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.drudis.2022.03.007","article-title":"Bacterial cancer therapy: a turning point for new paradigms","volume":"27","author":"Mayakrishnan","year":"2022","journal-title":"Drug Discovery Today"},{"key":"B43","doi-asserted-by":"publisher","first-page":"n1560","DOI":"10.1136\/bmj.n1560","article-title":"Glioblastoma: clinical presentation, diagnosis, and management","volume":"374","author":"McKinnon","year":"2021","journal-title":"BMJ"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.09.016","article-title":"Salmonella-mediated blood\u2212brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo\/bacterial glioma therapy","volume":"13","author":"Mi","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163448","article-title":"Targeting fatty acid metabolism in glioblastoma","volume":"133","author":"Miska","year":"2023","journal-title":"J. Clin. Invest."},{"key":"B45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","article-title":"Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202100241","article-title":"Cell\/Bacteria-based bioactive materials for cancer immune modulation and precision therapy","volume":"33","author":"Pan","year":"2021","journal-title":"Adv. Mater"},{"key":"B47","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cancers15030866","article-title":"Gut microbiota in colorectal cancer: biological role and therapeutic opportunities","volume":"15","author":"Pandey","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"21002","DOI":"10.1038\/s41598-020-77919-w","article-title":"Glioma and temozolomide induced alterations in gut microbiome","volume":"10","author":"Patrizz","year":"2020","journal-title":"Sci. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"12938","DOI":"10.1093\/nar\/gkac1164","article-title":"Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions","volume":"50","author":"Robledo","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/pharmaceutics13121984","article-title":"Bacteria from infectious particles to cell based anticancer targeted drug delivery systems","volume":"13","author":"Salem-Bekhit","year":"2021","journal-title":"Pharmaceutics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1039\/D2BM01593E","article-title":"Engineered bacteria for augmented in situ tumor vaccination","volume":"11","author":"Shen","year":"2023","journal-title":"Biomater Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41467-022-32837-5","article-title":"Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bioactmat.2022.10.024","article-title":"Bacterial extracellular vesicle applications in cancer immunotherapy","volume":"22","author":"Suri","year":"2023","journal-title":"Bioact Mater"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c10501","article-title":"Ready-to-Use-Type lyophilized lipid nanoparticle formulation for the postencapsulation of messenger RNA","volume":"17","author":"Tanaka","year":"2023","journal-title":"ACS Nano"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/ijms19061632","article-title":"Bacterial toxins and targeted brain therapy: new insights from cytotoxic necrotizing factor 1 (CNF1)","volume":"19","author":"Tantillo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/toxins13030194","article-title":"CTX-CNF1 recombinant protein selectively targets glioma cells In Vivo","volume":"13","author":"Vannini","year":"2021","journal-title":"Toxins (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/neuonc\/now114","article-title":"Electrophysiology of glioma: a rho GTPase-activating protein reduces tumor growth and spares neuron structure and function","volume":"18","author":"Vannini","year":"2016","journal-title":"Neuro Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/1471-2407-14-449","article-title":"The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model","volume":"14","author":"Vannini","year":"2014","journal-title":"BMC Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1039\/D2BM01534J","article-title":"Injectable local drug delivery systems for glioblastoma: a systematic review and meta-analysis of progress to date","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"188846","DOI":"10.1016\/j.bbcan.2022.188846","article-title":"Intratumoral bacteria are an important \"accomplice\" in tumor development and metastasis","volume":"1878","author":"Wang","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.986837","article-title":"Bifidobacterium lactis combined with lactobacillus plantarum inhibit glioma growth in mice through modulating PI3K\/AKT pathway and gut microbiota","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1021\/acsami.2c19960","article-title":"Magnetotactic bacteria-based drug-loaded micromotors for highly efficient magnetic and biological double-targeted tumor therapy","volume":"15","author":"Wang","year":"2023","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.746568","article-title":"Association between oral microbiota and human brain glioma grade: a case-control study","volume":"12","author":"Wen","year":"2021","journal-title":"Front. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1002\/1878-0261.12787","article-title":"AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response","volume":"14","author":"Xia","year":"2020","journal-title":"Mol. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41368-022-00212-1","article-title":"Systemic antibiotics increase microbiota pathogenicity and oral bone loss","volume":"15","author":"Yuan","year":"2023","journal-title":"Int. J. Oral. Sci."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207198","article-title":"Near-infrared nano-optogenetic activation of cancer immunotherapy via engineered bacteria","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1164654\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T01:27:10Z","timestamp":1682990830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1164654\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":67,"alternative-id":["10.3389\/fcimb.2023.1164654"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1164654","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"article-number":"1164654"}}